Safety Study of Abatacept to Treat Refractory Sarcoidosis

Stopped early · Phase 2

Conditions studied: Sarcoidosis

In brief

The purpose of this study is to determine how safe and effective Abatacept is in treating patients who have progressive pulmonary sarcoidosis.

Key facts

Study ID

NCT00739960

Run by

University of Chicago

People needed

1

Starts

2008-08-01

Expected to finish

2008-12-01

Last updated by the study team

2020-03-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• The University of Chicago — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.